Dr Andrew Bassett, the Head of Research at the Wellcome Trust Sanger Institute has endorsed the use of Elpis cells in research. The Elpis cortical neurons were recently adopted as the platform of choice for large scale CRISPR/Cas9 screens at the Sanger Institute in Cambridge, as part of the Open Targets Project. This is a significant step in the validation of Elpis technology.

The cells were found to be particularly suitable for this research purpose because of their high purity and consistency. “These cells enable us to pick up on particularly subtle phenotypes,” said Dr Bassett. “They offer a powerful and reproducible model for these types of screens.”

Categories: News